SPCE vs. CLOV, RKLB, SNCY, ULH, CVLG, FIP, ASC, SB, ESEA, and CLCO
Should you be buying Virgin Galactic stock or one of its competitors? The main competitors of Virgin Galactic include Clover Health Investments (CLOV), Rocket Lab (RKLB), Sun Country Airlines (SNCY), Universal Logistics (ULH), Covenant Logistics Group (CVLG), FTAI Infrastructure (FIP), Ardmore Shipping (ASC), Safe Bulkers (SB), Euroseas (ESEA), and Cool (CLCO).
Virgin Galactic vs. Its Competitors
Virgin Galactic (NYSE:SPCE) and Clover Health Investments (NASDAQ:CLOV) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.
In the previous week, Virgin Galactic and Virgin Galactic both had 4 articles in the media. Clover Health Investments' average media sentiment score of 1.23 beat Virgin Galactic's score of 0.06 indicating that Clover Health Investments is being referred to more favorably in the news media.
Virgin Galactic has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500.
46.6% of Virgin Galactic shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.3% of Virgin Galactic shares are owned by company insiders. Comparatively, 24.1% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Virgin Galactic currently has a consensus target price of $4.81, suggesting a potential upside of 53.51%. Clover Health Investments has a consensus target price of $4.37, suggesting a potential upside of 66.03%. Given Clover Health Investments' stronger consensus rating and higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Virgin Galactic.
Clover Health Investments has a net margin of -2.68% compared to Virgin Galactic's net margin of -17,828.03%. Clover Health Investments' return on equity of -12.20% beat Virgin Galactic's return on equity.
Clover Health Investments has higher revenue and earnings than Virgin Galactic. Clover Health Investments is trading at a lower price-to-earnings ratio than Virgin Galactic, indicating that it is currently the more affordable of the two stocks.
Summary
Clover Health Investments beats Virgin Galactic on 11 of the 14 factors compared between the two stocks.
Get Virgin Galactic News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPCE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SPCE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Virgin Galactic Competitors List
Related Companies and Tools
This page (NYSE:SPCE) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access